Desmopressin acetate

Desmopressin acetate is a synthetic analog of vasopressin, used primarily to treat central diabetes insipidus and nocturnal enuresis. The material supplied by Suzhou Kernel Pharmaceutical Technology Co., Ltd. meets HPLC purity of at least 98.50%, with total impurities not exceeding 1.50% and the largest single impurity capped at 0.50%. Assay values fall within 95.0% to 105.0%, and water content by Karl Fischer is limited to 6.0% maximum. Acetic acid content is controlled between 3.0% and 8.0%, aligning with pharmacopeial expectations for active pharmaceutical ingredients.

The compound is synthesized under controlled conditions to ensure consistent stereochemistry, with specific optical rotation measured between -72.0° and -82.0°, indicating correct chiral configuration. Bacterial endotoxins are held below 500 EU/mg, a critical threshold for parenteral use. This grade is not intended for direct human administration without further formulation but is suitable for use in API manufacturing under GMP conditions. The specification profile reflects typical requirements for pharmaceutical intermediates in global markets, particularly in Europe and North America.

Buyers include generic drug manufacturers, contract development and manufacturing organizations, and research institutions requiring high-purity reference standards. The product is supplied in sealed, nitrogen-purged containers under controlled temperature conditions. Packaging is typically in 1kg or 5kg HDPE drums with desiccant, though custom packaging can be arranged. Lead time and minimum order quantities must be confirmed directly with the supplier, as these are not published.

Suzhou Kernel Pharmaceutical Technology Co., Ltd. is a supplier based in Suzhou, Jiangsu Province, China, with a physical address on Xuqing Road in the New District. The company is categorized as an imported supplier with harbor trust tier, indicating verified export compliance and shipping capability. There is no public information on years in operation, employee count, or revenue. The listing confirms active engagement in pharmaceutical ingredient supply but does not state GMP certification, client names, or regulatory audit history.

The supplier’s profile shows no recorded response rate or average response time, suggesting limited or no direct communication channel on the platform. However, the detailed technical specifications provided indicate internal analytical capability and process control. Buyers should treat this as a technical supplier focused on API intermediates, not a full-service pharmaceutical manufacturer. Quality documentation such as COA and SDS is available upon request, but no certificates are listed as pre-issued.